A proposal for staging COVID‐19 coagulopathy

Coronavirus disease 2019 (COVID‐19) is associated with significant hypercoagulability. However, despite prophylactic anticoagulation, critically ill patients with this condition develop thromboses. This forum discusses the lungs as the epicenter for the hemostatic issues, puts forward a proposal for...

Descripción completa

Detalles Bibliográficos
Autores principales: Thachil, Jecko, Cushman, Mary, Srivastava, Alok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Forum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7272892/
https://www.ncbi.nlm.nih.gov/pubmed/32685880
http://dx.doi.org/10.1002/rth2.12372
Descripción
Sumario:Coronavirus disease 2019 (COVID‐19) is associated with significant hypercoagulability. However, despite prophylactic anticoagulation, critically ill patients with this condition develop thromboses. This forum discusses the lungs as the epicenter for the hemostatic issues, puts forward a proposal for staging COVID‐19 coagulopathy based on available diagnostic markers, and suggest considering current and future treatment options based on these different stages.

Ejemplares similares